Biofil Chemicals & Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 524396 | NSE: BIOFILCHEM | Pharmaceuticals & Drugs | Small Cap

Biofil Chem & Pharma Share Price

59.82 -0.77 -1.27%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Biofil Chem & Pharma

M-Cap below 100cr DeciZen not available

Biofil Chemicals & Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
146.83
Market Cap:
98.2 Cr.
52-wk low:
40.7
52-wk high:
78.8

Is Biofil Chemicals & Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Biofil Chemicals & Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biofil Chemicals & Pharmaceuticals Ltd is a below average quality company.

2. Is Biofil Chemicals & Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Biofil Chemicals & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Biofil Chemicals & Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biofil Chemicals & Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Biofil Chem & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Biofil Chemicals & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 6%6.6%7.5%14.5%4%4%8.2%7.9%4.3%3.4%-
Value Creation
Index
-0.6-0.5-0.50.0-0.7-0.7-0.4-0.4-0.7-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7.25.913.213.512.423.129.735.822.43038
Sales YoY Gr.--18.3%124.7%2.1%-8.1%87.1%28.4%20.4%-37.4%34.2%-
Adj EPS 0.30.40.51.10.30.30.70.80.40.30.4
YoY Gr.-12.5%33.3%129.2%-73.6%3.5%146.7%2.7%-43.4%-20.9%-
BVPS (₹) 2.52.94.47.88.18.49.29.910.410.610.9
Adj Net
Profit
0.50.60.81.80.50.51.21.20.70.61
Cash Flow from Ops. 0.200.10.70.51.30.91.1-0.2-0.1-
Debt/CF from Ops. 13.6325.61023.41.31.30.4-2.1-4.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.3%19.4%0.4%34.2%
Adj EPS 0.7%3.2%-22.8%-20.9%
BVPS17.4%5.6%5.1%2.7%
Share Price 41% 55.4% -4.7% 43.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
6.87.28.115.23.63.68.584.23.33.8
Op. Profit
Mgn %
13.512.56.619.57.64.46.14.563.93.3
Net Profit
Mgn %
7.2105.913.33.82.14.13.53.11.91.7
Debt to
Equity
0.70.60.20.10.10.10.1000-
Working Cap
Days
24030627137139722328228126219280
Cash Conv.
Cycle
05143311396851657410126

Recent Performance Summary

Sales growth is good in last 4 quarters at 362.70%

Return on Equity has declined versus last 3 years average to 3.80%

Sales growth has been subdued in last 3 years 0.39%

Net Profit has been subdued in last 3 years -22.84%

Latest Financials - Biofil Chemicals & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0.4 -
TTM Sales (₹ Cr.) 38.5 -
BVPS (₹.) 10.9 -
Reserves (₹ Cr.) 1 -
P/BV 5.53 -
PE 146.83 -
From the Market
52 Week Low / High (₹) 40.66 / 78.80
All Time Low / High (₹) 0.30 / 352.45
Market Cap (₹ Cr.) 98.2
Equity (₹ Cr.) 16.3
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Biofil Chem & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Biofil Chem & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales7.175.8613.1713.4512.3623.1329.6935.7522.3830.04
Operating Expenses 6.215.1312.3010.8311.4222.1127.8734.1521.0528.87
Manufacturing Costs0.550.540.850.910.480.581.040.590.450.49
Material Costs4.733.8510.528.519.7719.9925.3132.4319.4627.42
Employee Cost 0.410.500.480.530.730.890.860.750.790.62
Other Costs 0.510.240.440.880.450.640.650.380.350.33
Operating Profit 0.970.730.872.620.941.021.821.601.331.17
Operating Profit Margin (%) 13.5%12.5%6.6%19.5%7.6%4.4%6.1%4.5%6.0%3.9%
Other Income 0.060.460.530.140.100.100.170.800.150.10
Interest 0.150.210.150.160.150.160.120.070.040.04
Depreciation 0.220.250.260.280.300.370.410.410.430.43
Exceptional Items 0000000000
Profit Before Tax 0.650.740.982.310.590.601.461.921.010.79
Tax 0.130.150.200.520.120.120.260.680.320.23
Profit After Tax 0.520.590.781.790.470.481.211.240.700.56
PAT Margin (%) 7.2%10.0%5.9%13.3%3.8%2.1%4.1%3.5%3.1%1.9%
Adjusted EPS (₹)0.30.40.51.10.30.30.70.80.40.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 7.868.4110.9112.7013.1713.6514.8816.1316.8417.30
Share Capital 16.2716.2716.2716.2716.2716.2716.2716.2716.2716.27
Reserves -8.41-7.86-5.37-3.58-3.11-2.62-1.39-0.140.561.03
Minority Interest0000000000
Debt2.872.981.371.431.561.641.190.430.460.52
Long Term Debt0000000000
Short Term Debt2.872.981.371.431.561.641.190.430.460.52
Trade Payables3.642.1111.597.109.148.5825.9215.850.6012.65
Others Liabilities 0.230.250.260.620.290.340.370.830.830.93
Total Liabilities 14.6013.7624.1321.8424.1524.2142.3633.2418.7331.41

Fixed Assets

Gross Block10.6810.8511.049.459.8311.2411.4511.5511.6211.63
Accumulated Depreciation1.511.792.060.290.580.951.361.772.202.63
Net Fixed Assets9.179.068.989.169.2510.2910.099.789.429
CWIP 0000000000
Investments 0000000000
Inventories0.270.170.100.171.021.191.694.341.291.21
Trade Receivables4.103.6513.9811.4612.9812.0329.7117.227.1720.50
Cash Equivalents 0.180.130.180.310.370.140.260.440.140.04
Others Assets0.870.750.890.740.530.570.621.460.700.65
Total Assets 14.6013.7624.1321.8424.1524.2142.3633.2418.7331.41

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0.210.010.140.710.461.260.891.11-0.22-0.11
PBT 0.650.740.982.310.590.601.461.921.010.79
Adjustment 0.370.460.420.450.450.530.560.480.480.38
Changes in Working Capital -0.52-0.84-0.96-1.84-0.070.25-0.87-0.62-1.4-1.05
Tax Paid -0.14-0.13-0.15-0.20-0.50-0.11-0.25-0.68-0.32-0.23
Cash Flow From Investing Activity -0.24-0.17-0.19-0.48-0.38-1.41-0.21-0.10-0.07-0.01
Capex -0.24-0.17-0.19-0.48-0.38-1.41-0.21-0.10-0.07-0.01
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 0.080.110.10-0.11-0.02-0.08-0.57-0.83-0.010.02
Net Proceeds from Shares 001.710000000
Net Proceeds from Borrowing 0.080.1100000000
Interest Paid 000-0.16-0.15-0.16-0.12-0.07-0.04-0.04
Dividend Paid 0000000000
Others 00-1.610.060.130.08-0.45-0.760.030.06
Net Cash Flow 0.05-0.050.050.130.06-0.240.120.18-0.30-0.11
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)13.5313.4713.2818.093.643.68.468.014.243.28
ROCE (%)12.0912.9714.0421.865.135.0610.1212.186.234.76
Asset Turnover Ratio0.510.410.70.590.540.960.890.950.861.2
PAT to CFO Conversion(x)0.40.020.180.40.982.630.740.9-0.31-0.2
Working Capital Days
Receivable Days189241244345361197257240199168
Inventory Days151444181718314615
Payable Days26027223840130316224923515488

Biofil Chemicals & Pharmaceuticals Ltd Stock News

Biofil Chemicals & Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Biofil Chem & Pharma on 28-Mar-2024 16:01 is ₹59.82.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Biofil Chem & Pharma stood at ₹98.23.
The latest P/E ratio of Biofil Chem & Pharma as of 28-Mar-2024 16:01 is 146.8.
The latest P/B ratio of Biofil Chem & Pharma as of 28-Mar-2024 16:01 is 5.53.
The 52-week high of Biofil Chem & Pharma is ₹78.80 and the 52-week low is ₹40.66.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biofil Chem & Pharma is ₹38.45 ( Cr.) .

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Its plant is located at Plot No. 8, Sector-IV Kheda Industrial Estate, Pithampur, Dhar District, Madhya Pradesh. The facility has received GMP certificate from Licensing Authority, Food & Drugs Administration, Department of Health and Government of Madhya Pradesh, India.

The manufacturing unit exports around 30 to 40% of their formulation directly or through merchant export to countries in own or neutral labels.

The shares of companies are listed on Bombay Stock Exchange.

Company exports its products to countries namely Kenya, Uganda, Tanzania, Nigeria, U.A.E, Rwanda, Monrovia, Republic of Yemen and Mauritius.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.